Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 10366108)

Published in Arthritis Rheum on June 01, 1999

Authors

D H Manicourt1, R D Altman, J M Williams, J P Devogelaer, A Druetz-Van Egeren, M E Lenz, D Pietryla, E J Thonar

Author Affiliations

1: Université de Louvain, International Institute of Cellular and Molecular Pathology, and Saint-Luc University Hospital, Brussels, Belgium.

Articles citing this

Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol (2010) 1.33

A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord (2008) 1.30

Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol (2013) 1.15

Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis (2006) 1.14

Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow. Arthritis Res Ther (2006) 1.11

Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model. Arthritis Res Ther (2011) 1.11

Salmon calcitonin: a review of current and future therapeutic indications. Osteoporos Int (2007) 1.02

Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation. BMC Musculoskelet Disord (2010) 0.95

The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep (2013) 0.95

Osteoblast-chondrocyte interactions in osteoarthritis. Curr Osteoporos Rep (2014) 0.95

Osteoporotic changes of subchondral trabecular bone in osteoarthritis of the knee: a 3-T MRI study. Osteoporos Int (2011) 0.88

A posteriori comparison of natural and surgical destabilization models of canine osteoarthritis. Biomed Res Int (2013) 0.85

Effects of long-term estrogen replacement therapy on the prevalence and area of periarticular tibial osteophytes in surgically postmenopausal cynomolgus monkeys. Bone (2007) 0.84

Subchondral bone plate thickening precedes chondrocyte apoptosis and cartilage degradation in spontaneous animal models of osteoarthritis. Biomed Res Int (2014) 0.81

Identification of the calcitonin receptor in osteoarthritic chondrocytes. BMC Res Notes (2011) 0.81

Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy. Eur J Clin Pharmacol (2009) 0.79

Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-β in chondrocytes. Sci Rep (2016) 0.76

Inhalation therapy of calcitonin relieves osteoarthritis of the knee. J Korean Med Sci (2012) 0.76

Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res (2016) 0.75

Review of Soluble Biomarkers of Osteoarthritis: Lessons From Animal Models. Cartilage (2016) 0.75

Articles by these authors

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99

OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52

Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol (2000) 7.28

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science (1997) 7.07

A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev (1999) 6.34

Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem (1995) 5.57

Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum (1995) 5.32

Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum (1988) 4.60

OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34

Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol (1993) 4.12

OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage (2004) 4.01

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67

Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology (2000) 3.34

Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. Arthritis Rheum (1995) 3.05

Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol (1983) 2.95

Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med (1983) 2.94

Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis (2004) 2.89

Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis. Arthritis Rheum (1998) 2.89

How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behav Res Ther (1995) 2.84

Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage (2000) 2.42

Autobiographical memory in suicide attempters. J Abnorm Psychol (1986) 2.41

DiOC6 staining reveals organelle structure and dynamics in living yeast cells. Cell Motil Cytoskeleton (1993) 2.39

Ferritin mutants of Escherichia coli are iron deficient and growth impaired, and fur mutants are iron deficient. J Bacteriol (1999) 2.37

The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol (2000) 2.33

Autobiographical memory in depression: state or trait marker? Br J Psychiatry (1993) 2.24

Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum (1995) 2.23

The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14

Hospital preparedness for weapons of mass destruction incidents: an initial assessment. Ann Emerg Med (2001) 2.09

Angioid streaks. Surv Ophthalmol (1982) 2.02

Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci (1994) 1.93

Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1991) 1.92

PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet (1997) 1.84

Lower quit rates among African American and Latino menthol cigarette smokers at a tobacco treatment clinic. Int J Clin Pract (2009) 1.82

Quantification of keratan sulfate in blood as a marker of cartilage catabolism. Arthritis Rheum (1985) 1.82

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res (2000) 1.80

Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol (2001) 1.72

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA (2001) 1.72

Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet (2000) 1.71

Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Am J Ophthalmol (1997) 1.70

Techniques for tracing past employees. An example from an asbestos factory. Br J Prev Soc Med (1967) 1.69

Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci U S A (1994) 1.69

Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation. Arthritis Rheum (1995) 1.67

Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage (2006) 1.64

Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus (1995) 1.63

IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int (2006) 1.59

Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthritis Cartilage (2008) 1.50

Intravertebral vacuum cleft: changes in content after supine positioning. Radiology (1993) 1.50

Development of clinical criteria for osteoarthritis. J Rheumatol (1987) 1.46

Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type I. J Clin Endocrinol Metab (1981) 1.45

Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum (1996) 1.42

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med (1973) 1.41

Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. Osteoarthritis Cartilage (2003) 1.41

Suicide prevention in Gotland. Br J Psychiatry (1994) 1.40

Field evaluation of Haemophilus somnus bacterin. Vet Med Small Anim Clin (1977) 1.38

Bone mass evolution after renal transplantation. Kidney Int (2001) 1.38

Biochemical changes in progressive osteoarthrosis. Ann Rheum Dis (1977) 1.37

Left atrial isolation: new technique for the treatment of supraventricular arrhythmias. J Thorac Cardiovasc Surg (1980) 1.36

Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35

Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix (1992) 1.35

Musculoskeletal manifestations of Paget's disease of bone. Arthritis Rheum (1980) 1.29

A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol Med (1996) 1.28

The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rabbit. Osteoarthritis Cartilage (2010) 1.27

Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol (2006) 1.27

Immunogenicity of a Haemophilus somnus bacterin in cattle. Am J Vet Res (1978) 1.27

Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage (1998) 1.26

Correlations between immediate early gene induction and the persistence of long-term potentiation. Neuroscience (1993) 1.26

Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum (2000) 1.25

Inhomogeneity of human vertebral cancellous bone: systematic density and structure patterns inside the vertebral body. Bone (2001) 1.24

Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med (1988) 1.23

Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma. Arthritis Rheum (1973) 1.22

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21

On the structure of hemosiderin and its relationship to ferritin. J Ultrastruct Res (1971) 1.21

Tumor invasion and host extracellular matrix. Cancer Metastasis Rev (1983) 1.20

Metabolism of the extracellular matrix formed by intervertebral disc cells cultured in alginate. Spine (Phila Pa 1976) (1997) 1.20

Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol (2001) 1.19

Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes. J Immunol (1984) 1.19

Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthritis Cartilage (2006) 1.19

Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum (1993) 1.18

Depression and social problem solving. J Abnorm Psychol (1992) 1.18

Athletic injury, psychosocial factors and perceptual changes during stress. J Sports Sci (1999) 1.18

Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors. Neuropharmacology (2001) 1.17

Collagenolytic activity and collagen matrix breakdown of the articular cartilage in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum (1983) 1.16

Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control (2004) 1.16

Markers of cartilage matrix metabolism in human joint fluid and serum: the effect of exercise. Osteoarthritis Cartilage (1995) 1.16

Effective problem solving in suicide attempters depends on specific autobiographical recall. Suicide Life Threat Behav (2001) 1.16

Digital clubbing and lung cancer. Chest (1998) 1.15

Effects of extreme heat on teeth with implications for histologic processing. J Forensic Sci (1999) 1.15

The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol (1984) 1.14

[Articular amyloidosis, femoral neck fracture and chronic periodic hemodialysis]. Rev Rhum Mal Osteoartic (1985) 1.13

Reconstituted and native iron-cores of bacterioferritin and ferritin. J Mol Biol (1987) 1.13

The genetic influence on bone susceptibility to fluoride. Bone (2006) 1.13

Age-related changes in articular cartilage proteoglycans: electron microscopic studies. J Orthop Res (1985) 1.12

Measures of injury severity in childhood: a critical overview. Inj Prev (1998) 1.12

Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Ophthalmology (1996) 1.12